# Fresenius Kabi AB – FDA Inspection, Feb 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ab/5335bdf2-a6c2-4615-9a8d-e8c7eb43064f
Source feed: FDA_Inspections

> FDA inspection 1005000 of Fresenius Kabi AB, February 07, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005000
- Company Name: Fresenius Kabi AB
- Inspection Date: 2017-02-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1238177 - 2023-04-21
- FDA Inspection 1155467 - 2020-10-15
- [FDA Inspection 1099421 - 2018-10-16](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ab/601d4a6e-431f-4514-affd-3f8945416a3c)
- FDA Inspection 925969 - 2015-03-20
- FDA Inspection 876533 - 2014-04-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/steven-p-donald/431cb518-7687-408b-82e4-e525a135a26b)
- [Issuing Officer](https://www.keypedia.com/people/tiara-n-brown-crosen/8255649d-25a9-49fa-a28d-0cdda922c0c3)

Company: https://www.keypedia.com/companies/fresenius-kabi-ab/95acd39b-72be-48a9-aa55-38713a33c8cc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
